New York Life Investment Management LLC Has $18.71 Million Stake in Lam Research Corporation $LRCX

New York Life Investment Management LLC lifted its position in shares of Lam Research Corporation (NASDAQ:LRCXFree Report) by 0.8% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 192,258 shares of the semiconductor company’s stock after purchasing an additional 1,472 shares during the quarter. New York Life Investment Management LLC’s holdings in Lam Research were worth $18,714,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of LRCX. Smallwood Wealth Investment Management LLC acquired a new position in shares of Lam Research during the first quarter worth approximately $26,000. IMG Wealth Management Inc. acquired a new position in shares of Lam Research during the second quarter worth approximately $26,000. REAP Financial Group LLC acquired a new position in shares of Lam Research during the second quarter worth approximately $31,000. 1 North Wealth Services LLC acquired a new position in shares of Lam Research during the first quarter worth approximately $36,000. Finally, Rossby Financial LCC acquired a new position in shares of Lam Research during the first quarter worth approximately $37,000. 84.61% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Lam Research

In other news, SVP Vahid Vahedi sold 52,190 shares of the stock in a transaction on Monday, October 13th. The stock was sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the completion of the transaction, the senior vice president owned 251,047 shares in the company, valued at approximately $34,870,428.30. This represents a 17.21% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.31% of the company’s stock.

Lam Research Trading Up 3.4%

Shares of Lam Research stock opened at $156.90 on Tuesday. Lam Research Corporation has a 1 year low of $56.32 and a 1 year high of $158.25. The firm has a market cap of $197.86 billion, a PE ratio of 34.56, a P/E/G ratio of 1.66 and a beta of 1.84. The stock has a fifty day moving average price of $124.39 and a 200-day moving average price of $100.67. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.60.

Lam Research (NASDAQ:LRCXGet Free Report) last announced its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.04. The firm had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The business’s revenue was up 27.7% compared to the same quarter last year. During the same period last year, the firm posted $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Equities research analysts anticipate that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, September 24th were paid a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a dividend yield of 0.7%. The ex-dividend date was Wednesday, September 24th. This is a positive change from Lam Research’s previous quarterly dividend of $0.23. Lam Research’s dividend payout ratio is currently 22.91%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on LRCX shares. The Goldman Sachs Group increased their price target on Lam Research from $115.00 to $160.00 and gave the company a “buy” rating in a research report on Wednesday, October 8th. Oppenheimer set a $200.00 price target on Lam Research and gave the company an “outperform” rating in a research report on Thursday. B. Riley increased their price target on Lam Research from $160.00 to $175.00 and gave the company a “buy” rating in a research report on Monday, October 20th. Raymond James Financial increased their price target on Lam Research from $90.00 to $110.00 and gave the company an “outperform” rating in a research report on Thursday, July 31st. Finally, TD Cowen increased their price target on Lam Research from $145.00 to $170.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. One analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat, Lam Research currently has an average rating of “Moderate Buy” and an average price target of $148.83.

View Our Latest Analysis on LRCX

About Lam Research

(Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

See Also

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.